Filing Details

Accession Number:
0001567619-22-013890
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-11 20:42:34
Reporting Period:
2022-07-07
Accepted Time:
2022-07-11 20:42:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528115 Annexon Inc. ANNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315797 A Muneer Satter C/O Annexon, Inc.
1400 Sierra Pt Pkwy, Bldg C, 2Nd Floor
Brisbane CA 94005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-07 2,453,988 $3.84 4,408,966 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Acquisiton 2022-07-07 613,497 $0.13 613,497 $5.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
613,497 2022-07-11 2025-06-30 No 4 P Indirect
Footnotes
  1. Reflects shares that were purchased from the Issuer on July 7, 2022 in a private offering pursuant to a Securities Purchase Agreement, dated July 7, 2022. The shares were purchased by Satter Medical Technology Partners II, L.P. ("SMTP II") for which the Reporting Person has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
  2. Includes (a) 240,000 shares that are held by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares, (b) 567,240 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares, (c) 1,147,738 shares that are held by Satter Medical Technology Partners, L.P. for which the Reporting Person has sole voting and dispositive power over all such shares and (d) 2,453,988 shares that are held by SMTP II for which the Reporting Person has sole voting and dispositive power of all such shares. The Reporting Person disclaims beneficial ownership of all shares included under (b), (c) and (d) of this footnote, except to the extent of his pecuniary interest.
  3. The warrants are held by SMTP II for which the Reporting Person has sole voting and dispositive power of all such warrants. The Reporting Person disclaims beneficial ownership of all the warrants, except to the extent of his pecuniary interest.